A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

PHASE3CompletedINTERVENTIONAL

Enrollment

395

Participants

Timeline

Start Date

April 29, 2003

Primary Completion Date

December 1, 2003

Study Completion Date

December 1, 2003

Conditions

Osteoarthritis

Interventions

DRUG

MK0966, rofecoxib

DRUG

Comparator: celecoxib, placebo

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00092352 - A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219) | Biotech Hunter | Biotech Hunter